Reprotech announced that the TMRW Vault has received CE marking as a Class IIa medical device under Regulation (EU) 2017/745, paving the way for commercialization in the European Union and other international markets that recognize the CE mark.
Digital Chain-of-Custody and Advanced Monitoring
The TMRW Vault combines digital chain-of-custody, advanced monitoring, and scalable cryostorage to help fertility clinics reduce risk, strengthen specimen traceability, and support growth. The system includes the TMRW Vault Freezer, a cryogenic freezer for liquid nitrogen storage of oocytes, embryos, and sperm, and the TMRW Vault Workstation, which facilitates sample transfer and order management through a software interface.
As fertility clinics manage rapidly growing volumes of frozen reproductive tissues, safer and more traceable storage solutions have become critical. Historically, manual storage systems have created operational inefficiencies and increased the potential for human error.
Integrated Solution with ivfOS Software
The TMRW Vault modernizes this process by combining advanced onsite cryostorage infrastructure with TMRW's proprietary ivfOS software platform. This integrated solution enables digital specimen identification, continuous monitoring, real-time inventory management, and secure digital chain-of-custody that strengthens specimen traceability.
The system includes RFID-enabled CryoBeacons for digital specimen management, manual access to the tech-enabled tank with full digital traceability, and advanced monitoring through TMRW Overwatch, which performs thousands of daily system checks supported by expert oversight.
Scalable and Efficient Storage
A single Vault tank can hold as much as ten traditional dewars in approximately one-third of the footprint, offering scalable storage capacity. The system also integrates seamlessly with the broader TMRW ecosystem and offsite cryostorage services, with simple installation enabling quick deployment.
This achievement follows the April 2026 business combination between Reprotech and TMRW Life Sciences, which brought together decades of cryostorage expertise and a U.S. national biorepository network with next-generation digital specimen management technologies. Together with Reprotech's acquisition of IMT Matcher in June 2025, the combined organization now offers fertility clinics one of the most comprehensive ecosystems spanning specimen witnessing, digital traceability, onsite and offsite cryostorage, consent management, and storage administration and billing.
